ESO–EANS Rewrites the Rulebook on Spontaneous ICH: First Update Since 2014
The European Stroke Organization (ESO) has recently shared an insightful post on X:
”The new ESO–EANS guideline on intracerebral haemorrhage outlines best practice for acute care, surgery, and blood pressure control.”
To access the guideline, read the full article here.
Thorsten Steiner et al. shade light on the management of intracerebral haemorrhage in a newly published ”European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage” in the SAGE Journals.
The European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) have updated their guidelines on spontaneous ICH for the first time since 2014.
Despite reviewing over 115,000 articles and including 208 studies, only a handful of strong recommendations emerged.
These include treating ICH patients in organised stroke units and lowering blood pressure to prevent recurrence.
- Strong evidence supports stroke unit care and blood pressure control for secondary prevention, while weak evidence backs prediction scores for macrovascular causes of ICH.
- Strong evidence discourages anti-inflammatory use outside trials, while weak evidence cautions against routine use of rFVIIa, platelet transfusions, early treatment restrictions, and isolated temperature or glucose control.
These and more findings highlight the ongoing need for high-quality trials embedded in clinical care.
Read the latest updates on thrombosis and bleeding disorders in Hemostasis Today.
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership